Kamil Slowikowski, Hung N Nguyen, Erika H Noss, Daimon P Simmons, Fumitaka Mizoguchi, Gerald F M Watts, Michael F Gurish, Michael B Brenner, Soumya Raychaudhuri
Proceedings of the National Academy of Sciences of the United States of America 2020 Mar 10The role of stromal fibroblasts in chronic inflammation is unfolding. In rheumatoid arthritis, leukocyte-derived cytokines TNF and IL-17A work together, activating fibroblasts to become a dominant source of the hallmark cytokine IL-6. However, IL-17A alone has minimal effect on fibroblasts. To identify key mediators of the synergistic response to TNF and IL-17A in human synovial fibroblasts, we performed time series, dose-response, and gene-silencing transcriptomics experiments. Here we show that in combination with TNF, IL-17A selectively induces a specific set of genes mediated by factors including cut-like homeobox 1 (CUX1) and IκBζ (NFKBIZ). In the promoters of CXCL1, CXCL2, and CXCL3, we found a putative CUX1-NF-κB binding motif not found elsewhere in the genome. CUX1 and NF-κB p65 mediate transcription of these genes independent of LIFR, STAT3, STAT4, and ELF3. Transcription of NFKBIZ, encoding the atypical IκB factor IκBζ, is IL-17A dose-dependent, and IκBζ only mediates the transcriptional response to TNF and IL-17A, but not to TNF alone. In fibroblasts, IL-17A response depends on CUX1 and IκBζ to engage the NF-κB complex to produce chemoattractants for neutrophil and monocyte recruitment.
Kamil Slowikowski, Hung N Nguyen, Erika H Noss, Daimon P Simmons, Fumitaka Mizoguchi, Gerald F M Watts, Michael F Gurish, Michael B Brenner, Soumya Raychaudhuri. CUX1 and IκBζ (NFKBIZ) mediate the synergistic inflammatory response to TNF and IL-17A in stromal fibroblasts. Proceedings of the National Academy of Sciences of the United States of America. 2020 Mar 10;117(10):5532-5541
PMID: 32079724
View Full Text